On Friday 5th August 2016, CTC's founding
director Professor John Simes was awarded the 2016 NSW Premier's
Award for Outstanding Cancer Researcher of the Year.
Prof Simes is a medical oncologist ...
Read More |
CTC is proud to have Associate Professor Rachael Morton
promoting gender equity and diversity, with her recent success as
an invited representative on the University's Science in Australia
Read More |
After a total of 16-years of follow-up, CTC's LIPID* trial has
now shown clearly that the higher survival rate due to 6 years of
statin treatment is sustained over a long period, mainly because of...
Read More ||
Annals of Oncology. Online 10 Aug 2016Lawrence N, Martin A, Toner G, Stockler M, Buizen L, Thomson D, Gebski V, Friedlander M, Yeung A, Wong N, Gurney H, Rosenthal M, Singhal N, Kichenadasse G, Wong S, Lewis C, Vasey P, Grimison P
BMC Nephrology 2016; 17(1): 113Ritte R, Luke J, Nelson C, Brown A, O'Dea K, Jenkins A, Best JD, McDermott R, Daniel M, Rowley K
BJU International. Online 19 July 2016.Emery JD, Jefford M, King M, Hayne D, Martin A, Doorey J, Hyatt A, Habgood E, Lim T, Hawks C, Pirotta M, Trevena L, Schofield P
Clinical Journal of the American Society of Nephrology. Online 10 Aug 2016Morton RL, Kurella Tamura M, Coast J, Davison SN